Myrobalan Therapeutics Holding, Inc.

Biotechnology company · Medford, Massachusetts, United States

Myrobalan Therapeutics Holding, Inc. is a biotechnology company headquartered in Medford, Massachusetts, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $24 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Myrobalan Therapeutics Holding at a glance

Typebiotechnology company

HeadquartersMedford, Massachusetts, United States

Earliest incorporation on record2023

SEC CIK2009058

What does Myrobalan Therapeutics Holding do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $24 million sold (2024).

Frequently asked questions about Myrobalan Therapeutics Holding

Where is Myrobalan Therapeutics Holding headquartered?

Myrobalan Therapeutics Holding, Inc. is headquartered in Medford, Massachusetts, United States.

What does Myrobalan Therapeutics Holding do?

Myrobalan Therapeutics Holding, Inc. is a biotechnology company.

When was Myrobalan Therapeutics Holding founded?

The earliest incorporation on record for Myrobalan Therapeutics Holding, Inc. is in 2023, according to public company registers.

Similar companies

Travera, Inc.Medford, Massachusetts, United States
Sentien Biotechnologies, Inc.Medford, Massachusetts, United States
Seventh Sense Biosystems, Inc.Medford, Massachusetts, United States
Sofregen Medical Inc.Medford, Massachusetts, United States
Greenlight Biosciences Inc.Medford, Massachusetts, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences